Biopharmaceuticals commonly called “biologics,” include a wide variety of products derived from human, animal, or microbial sources with the help of biotechnology. A surge of bio-APIs and their growing penetration into multiple therapies create an attractive market for pharmaceutical chemical suppliers.Continue reading
Author Archives: Shilpi Mehrotra, Project Manager
Growth of Biologics and Biosimilars Will Drive Above-Average Demand for a Range of Ingredients
A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.
Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading
Kline Confirms that Excipients are on the Rise in a New Era for Biologics and Topicals
The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
Performance vs. Cost: Demand Trends in Synthetic Latex Polymers
The market of synthetic latex polymers assumes a unique set of characteristics in every geography, from performance of the economy, purchasing power of the population, and industrialization to demand patterns, competition from alternate technologies, and performance of the polymers in specific end uses.
North America and China both represent the largest markets of synthetic latex polymers by volume, each accounting for an approximate 25% share of global consumption. Meanwhile, India, which has a much smaller share of around 5% of global consumption, is the fastest-growing market for synthetic latex polymers in the world. It is these three key geographical markets of North America, China, and India that Kline studies in depth this year in its continuous Synthetic Latex Polymers Global Series: Business Analysis and Opportunities program.Continue reading
Oral Solids Continue to Dominate the Excipients Market, While the Parenteral Route Accelerates Growth
By definition, excipients are inactive substances that serve as a medium or vehicle for pharmaceutical active drug substances. Over the years, excipients have been increasingly developed to provide important functionalities to pharmaceutical formulations. The global pharmaceutical market is worth more than USD 1.1 trillion as of 2017 and expected to grow more than 4% annually over the next five years. The global market of specialty excipients in the overall pharmaceutical industry is estimated at about USD 6.8 billion in 2017.Continue reading
Additive Manufacturing Technology: A Hotbed of Opportunities
The highly disruptive and rapidly growing additive manufacturing technology (AMT) promises a revolutionary change, not only in the large manufacturing industries, but also through average consumers. In addition to an economical alternative to traditional manufacturing, the 3D printing industry also provides the benefits of incorporating high levels of customization and complexity of design, as well as much lower lead times. This phenomenon of 3D printing, which until recently was mainly used for rapid prototyping, is now also increasingly being used in the production of end-parts and finished components in a wide range of applications, such as the automotive, aerospace, machine tools, electronics, medical, pharmaceuticals, and food industries.
3D printing has given rise to a rapidly growing multi-billion-dollar global market, offering highly profitable opportunities to companies along its supply chain. Continue reading
Middle East Synthetic Latex Polymers Market: A Unique Mix of Trends and Opportunities
The Middle East accounts for approximately 5% of the global consumption of synthetic latex polymers, with a market value of about USD 1.3 billion in 2016. This region represents an interesting mix of diverse economies, displaying a combination of varying market characteristics, ranging from the advanced Turkish market, which closely follows European trends, to the highly price-sensitive Egyptian market.
Like in most regions, except Southeast Asia, paints and coatings and adhesives and sealants are the largest application sectors in the Middle East. However, the region exhibits some striking differences in the application mix.Continue reading
The specialty excipients market for oral-solid-dosage-form pharmaceuticals will grow close to 6% during 2016-2021
Pharmaceuticals is one of the largest and most essential industries worldwide. The global pharmaceutical market is worth over USD 1.1 trillion as of 2016 and is expected to grow in the range of 4%-7% annually over the next five years. Among the several routes of drug administration prevalent in the pharmaceutical industry, oral route is the most widely used, accounting for around 55% of the global pharmaceuticals market value. Furthermore, within orals, solid formulations are the most preferred dosages for their ease of administration, dosage accuracy, stability, and cost-effectiveness. OSDFs is a key growth segment for the global healthcare industry, especially with the growing emphasis on expanding affordable healthcare. Continue reading